What is the main goal of the Nvidia and Eli Lilly joint lab?

The joint lab aims to accelerate drug discovery and development by utilizing advanced AI.

How much are Nvidia and Eli Lilly investing in the new AI lab?

Nvidia and Eli Lilly are investing a total of $1 billion over five years.

Which Nvidia AI chips will be used in the new research lab?

The new lab will use Nvidia's newest generation Vera Rubin AI chips.

Home / Business and Economy / Nvidia & Eli Lilly Forge $1B AI Research Alliance

Nvidia & Eli Lilly Forge $1B AI Research Alliance

12 Jan

•

Summary

Nvidia and Eli Lilly will invest $1 billion over five years.
A new joint research lab will be built in the San Francisco Bay area.
The lab will utilize Nvidia's advanced Vera Rubin AI chips.

Nvidia & Eli Lilly Forge $1B AI Research Alliance

Nvidia and Eli Lilly are set to invest $1 billion over the next five years to establish a new joint research laboratory in the San Francisco Bay area. This ambitious initiative will harness the power of Nvidia's latest generation Vera Rubin AI chips, signaling a major advancement in AI-driven pharmaceutical research. The collaboration was announced ahead of the JPMorgan Healthcare Conference, highlighting its strategic importance.

This partnership builds upon Eli Lilly's prior investment in Nvidia's Grace Blackwell AI chips for supercomputer development. Drugmakers like Lilly are increasingly turning to advanced AI models to expedite the design and discovery of new treatments, with the ultimate goal of reducing the time required to bring novel therapies to patients.

The new facility, with its exact location to be revealed in March, will host researchers from both Nvidia and Eli Lilly. They will collaborate to generate novel data essential for training advanced biotechnology AI models. Nvidia will supply open-source AI models and software, enabling drug developers to build their own platforms on Nvidia's hardware infrastructure.